Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-211926
Filing Date
2012-05-04
Accepted
2012-05-04 16:09:00
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d329789d10q.htm 10-Q 625746
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d329789dex311.htm EX-31.1 8373
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER d329789dex312.htm EX-31.2 8592
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER d329789dex32.htm EX-32 5424
  Complete submission text file 0001193125-12-211926.txt   2256843

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cadx-20120331.xml EX-101.INS 262322
6 XBRL TAXONOMY EXTENSION SCHEMA cadx-20120331.xsd EX-101.SCH 13296
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cadx-20120331_cal.xml EX-101.CAL 34388
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cadx-20120331_def.xml EX-101.DEF 6429
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cadx-20120331_lab.xml EX-101.LAB 116965
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cadx-20120331_pre.xml EX-101.PRE 78972
Mailing Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8584361400
CADENCE PHARMACEUTICALS INC (Filer) CIK: 0001333248 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33103 | Film No.: 12814389
SIC: 2834 Pharmaceutical Preparations